The head of a top Brazilian health research institute says its scientists have discovered the Zika virus in urine and saliva.» Read More
President Obama embraced Ebola nurse Nina Pham in the Oval Office at the White House after she was declared free of the often-deadly virus.
Global equity strategists pick out U.S. sectors and stocks that could be affected in Friday's trading session on the back of the NY Ebola case.
The House Oversight and Government Reform Committee is investigating the U.S. response to Ebola.
New York City's first Ebola case has raised complex issues of how to trace the possible contacts of an infected patient, the NYT reports.
Will Sam’s Club's health insurance exchange prompt small-business owners to offer insurance through the wholesaler, rather than opt for SHOP exchanges?
Should the zombie apocalypse come knocking, these are the 25 worst cities to seek refuge according to Trulia.
A doctor who recently treated Ebola patients in West Africa was taken with a fever and other symptoms to a New York City hospital.
Microsoft co-founder Paul Allen is quadrupling to $100 million his funding for efforts to combat the deadly Ebola virus.
Federal health officials revealed an $840 million program they hope will lead to better patient outcomes and reduced health-care costs.
A new email malware pretends to provide information about the disease, but it actually infects the computer with malicious programs.
Eli Lilly earnings plunged, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its full-year forecast.
The Dallas hospital that treated three Ebola patients has seen steep drop offs in patients and revenue since Oct. 1, a new report reveals.
Language in contracts health insurers must sign to sell coverage on HealthCare.gov will let them terminate their plans if premium subsidies cease.
The patient, who was taking Tecfidera, died earlier this month.
Former U.N. Secretary General has warned that a "dark cloud" could be cast over Africa if the press continued its scaremongering over Ebola.
GlaxoSmithKline (GSK) reported third-quarter revenue lower than analysts forecast, as sales of blockbuster asthma drug Advair continued to fall.
Nine in 10 uninsured Americans don't know that Obamacare's next open-enrollment period starts next month, a Kaiser survey finds.
A new Ebola vaccine could be ready to send to West Africa soon, NewLink Genetics' Charles Link says.
A Bulgarian man who was paralyzed can walk with the aid of a frame after receiving transplant treatment using cells from his nose.
AbbVie is walking away from its proposed $55 billion takeover bid of Shire and has agreed to pay the rival drugmaker a $1.64 billion breakup fee.
Get the best of CNBC in your inbox